Zishen pingchan granules combined with pramipexole in the improvement of depressive symptoms in Parkinson's disease: a prospective, multicenter, randomized, double-blind, controlled clinical study - Ning, Houxu; Zhou, Hao; Ren, Jingru; Zhou, Gaiyan; Yang, Ning; Wang, Zhenfu; Yuan, Canxing; Tian, Zuojun; Chen, Juping; Shen, Lihua; Zheng, Huifen; Zhao, Yang; et al. (Journal of translational medicine, 2022)
Keywords: Biomedical and Life Sciences; Biomedicine; Care and treatment; Chi-square test; Clinical trials; Complications and side effects; Depression in the Parkinson's disease; Depression, Mental; Development and progression; Double-blind studies; Drug dosages; Herbal medicine; Medicine, Chinese; Medicine/Public Health; Mental depression; Methods; Movement disorders; Neurodegenerative diseases; Neuroscience; Parkinson's disease; Patient outcomes; Patients; Pharmaceuticals; Placebos; Pramipexole; Quality of life; Randomized controlled trial; Remission; Remission (Medicine); Statistical analysis; Zishen Pingchan granules; China; Depression in the Parkinson's disease; Randomized controlled trial; Pramipexole; Zishen Pingchan granules